HD Biosciences Inc. (HDB) is a Shanghai-based  biotech company specializing in drug discovery  contract research. HDB brings its unique and outstanding expertise and has developed comprehensive technology platforms for services covering most of the drug discovery and preclinical research including assay development, high throughput drug screening, compound profiling, bioanalytical chemistry,  In vivo pharmacology, DMPK and hit-to-lead biology solutions, as well  as natural product-based lead discovery. The Company has provided extensive and high quality services for its clients including Pfizer, Shering Plough and other pharmaceutical and biotech companies and earned a prominent reputation in China as an indisputable leader in high value-added biology-based drug discovery CRO business.